Stock listing
A41BQ3 Stock Price, News, Filings & Events — Cellectar Biosciences, Inc.
Selected listing: A41BQ3 · LS · EUR · DE
This page tracks Cellectar Biosciences, Inc.'s A41BQ3:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A41BQ3:LS. A41BQ3:LS is the stock-level entry point for investors researching Cellectar Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cellectar Biosciences, Inc. (ticker: CLRB) is a public company based in the United States, specializing in the development of targeted therapies for cancer. With a market capitalization of approximately $19.3 million, Cellectar focuses on innovative treatments aimed at improving patient outcomes. The company is committed to advancing its proprietary drug delivery platform to enhance the effectiveness of cancer therapies.
- Ticker
- A41BQ3:LS
- Asset type
- Stock
- Market cap
- $23.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Cellectar Biosciences, Inc. A41BQ3:LS stock context
This page tracks Cellectar Biosciences, Inc.'s A41BQ3:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A41BQ3:LS. A41BQ3:LS is the stock-level entry point for investors researching Cellectar Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cellectar Biosciences, Inc. (ticker: CLRB) is a public company based in the United States, specializing in the development of targeted therapies for cancer. With a market capitalization of approximately $19.3 million, Cellectar focuses on innovative treatments aimed at improving patient outcomes. The company is committed to advancing its proprietary drug delivery platform to enhance the effectiveness of cancer therapies.
Latest news from Cellectar Biosciences, Inc.
Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
August 13, 2026
Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026
July 30, 2026
Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers
July 15, 2026
Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Mac...
June 1, 2026
Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026
May 11, 2026
Cellectar Biosciences, Inc. earnings calls
Cellectar Biosciences, Inc. (CLRB) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
Cellectar Biosciences, Inc. (CLRB) Q1 2026 Earnings Call
May 14, 2026 · Replay with transcript and chapters
Cellectar Biosciences, Inc. (CLRB) Q4 2025 Earnings Call
March 4, 2026 · Replay with transcript and chapters
Cellectar Biosciences, Inc. (CLRB) Q3 2025 Earnings Call
November 13, 2025 · Replay with transcript and chapters
Cellectar Biosciences, Inc. (CLRB) Q2 2025 Earnings Call
August 14, 2025 · Replay with transcript and chapters
Cellectar Biosciences, Inc. (CLRB) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Research Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc. investor report
Review AI stock analysis and investor report context for A41BQ3:LS.
Cellectar Biosciences, Inc. company profile
View the public company page for Cellectar Biosciences, Inc. on 6ix.
Cellectar Biosciences, Inc. news
Read company news and market updates connected to Cellectar Biosciences, Inc..
Cellectar Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Cellectar Biosciences, Inc..
Alternate listings
CLRB:NASDAQ
US · USD
Alternate listing for Cellectar Biosciences, Inc.; the primary context on this page is A41BQ3:LS.
CLRB:BOATS
US · USD
Alternate listing for Cellectar Biosciences, Inc.; the primary context on this page is A41BQ3:LS.
NV40:GETTEX
DE · EUR
Alternate listing for Cellectar Biosciences, Inc.; the primary context on this page is A41BQ3:LS.
A41BQ3:LSX
DE · EUR
Alternate listing for Cellectar Biosciences, Inc.; the primary context on this page is A41BQ3:LS.
NV40:FWB
DE · EUR
Alternate listing for Cellectar Biosciences, Inc.; the primary context on this page is A41BQ3:LS.
NV40:MUN
DE · EUR
Alternate listing for Cellectar Biosciences, Inc.; the primary context on this page is A41BQ3:LS.